{"id":20612,"date":"2024-09-20T11:49:26","date_gmt":"2024-09-20T11:49:26","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/?p=20612"},"modified":"2024-10-04T11:53:46","modified_gmt":"2024-10-04T11:53:46","slug":"ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/","title":{"rendered":"CE marking for substance-based medical devices and drug-device combination products"},"content":{"rendered":"<p style=\"text-align: right;\"><span class=\"td_text_highlight_marker_red td_text_highlight_marker\">BY COMPANIES<\/span><\/p>\n<p>The placing on the European market of drug-device combination products or substance-based medical devices is regulated by the MDR. Manufacturers must comply with the requirements of this regulation, and it is important to choose a Notified Body that understands the challenges medical device manufacturers face in bringing compliant products to market efficiently.<\/p>\n<p><strong>CE Marking for substance-based medical devices (Rule 21)<\/strong><\/p>\n<p>These types of medical devices are regulated by Rule 21 of the MDR and must comply with specific GSPRs.<\/p>\n<p><strong>CE Marking for combination medical devices (Article 117)<\/strong><\/p>\n<p>Article 117 of the MDR requires manufacturers of these devices to obtain a Notified Body Opinion (NBOp) confirming that the device complies with the relevant GSPR and to provide an NBOp report.<\/p>\n<h2>BSI&#8217;s Medicinal and Biologics team<\/h2>\n<p>BSI is a full scope <strong>Notified Body<\/strong> and UK Approved Body and its services combine efficiency with the integrity, independence and rigour that manufacturers expect from BSI.<br \/>\nThe Medicinal and Biologics team is an experienced team covering a wide range of <strong>medical devices<\/strong>: our experts have extensive experience in providing MDR Conformity Assessment services to the medical device sector, spanning MDR Rules 14, 18 &amp; 21, and for providing MDR Article 117 Notified Body Opinion (NBO) to the pharmaceutical sector<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BSI, full-scope Notified Body for all three types of devices pursuant to MDR and IVDR, is able to offer verification services for compliance with European directives about the production of medical devices<\/p>\n","protected":false},"author":32,"featured_media":20823,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[787,801],"tags":[],"class_list":{"0":"post-20612","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-business-en","8":"category-medical-devices"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CE marking for substance-based medical devices and drug-device combination products - MakingPharmaIndustry<\/title>\n<meta name=\"description\" content=\"BSI, full-scope Notified Body for all three types of devices pursuant to MDR and IVDR, is able to offer verification services for compliance with European directives about the production of medical devices\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CE marking for substance-based medical devices and drug-device combination products - MakingPharmaIndustry\" \/>\n<meta property=\"og:description\" content=\"BSI, full-scope Notified Body for all three types of devices pursuant to MDR and IVDR, is able to offer verification services for compliance with European directives about the production of medical devices\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-20T11:49:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-04T11:53:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/10\/AdobeStock_716611374-scaled.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/74848807effaacf75c805dd345082918\"},\"headline\":\"CE marking for substance-based medical devices and drug-device combination products\",\"datePublished\":\"2024-09-20T11:49:26+00:00\",\"dateModified\":\"2024-10-04T11:53:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/\"},\"wordCount\":209,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/10\/AdobeStock_716611374-scaled.jpeg\",\"articleSection\":[\"BUSINESS\",\"Medical devices\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/\",\"name\":\"CE marking for substance-based medical devices and drug-device combination products - MakingPharmaIndustry\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/10\/AdobeStock_716611374-scaled.jpeg\",\"datePublished\":\"2024-09-20T11:49:26+00:00\",\"dateModified\":\"2024-10-04T11:53:46+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/74848807effaacf75c805dd345082918\"},\"description\":\"BSI, full-scope Notified Body for all three types of devices pursuant to MDR and IVDR, is able to offer verification services for compliance with European directives about the production of medical devices\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/10\/AdobeStock_716611374-scaled.jpeg\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/10\/AdobeStock_716611374-scaled.jpeg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CE marking for substance-based medical devices and drug-device combination products\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/74848807effaacf75c805dd345082918\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CE marking for substance-based medical devices and drug-device combination products - MakingPharmaIndustry","description":"BSI, full-scope Notified Body for all three types of devices pursuant to MDR and IVDR, is able to offer verification services for compliance with European directives about the production of medical devices","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/","og_locale":"en_US","og_type":"article","og_title":"CE marking for substance-based medical devices and drug-device combination products - MakingPharmaIndustry","og_description":"BSI, full-scope Notified Body for all three types of devices pursuant to MDR and IVDR, is able to offer verification services for compliance with European directives about the production of medical devices","og_url":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2024-09-20T11:49:26+00:00","article_modified_time":"2024-10-04T11:53:46+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/10\/AdobeStock_716611374-scaled.jpeg","type":"image\/jpeg"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/74848807effaacf75c805dd345082918"},"headline":"CE marking for substance-based medical devices and drug-device combination products","datePublished":"2024-09-20T11:49:26+00:00","dateModified":"2024-10-04T11:53:46+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/"},"wordCount":209,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/10\/AdobeStock_716611374-scaled.jpeg","articleSection":["BUSINESS","Medical devices"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/","url":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/","name":"CE marking for substance-based medical devices and drug-device combination products - MakingPharmaIndustry","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/10\/AdobeStock_716611374-scaled.jpeg","datePublished":"2024-09-20T11:49:26+00:00","dateModified":"2024-10-04T11:53:46+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/74848807effaacf75c805dd345082918"},"description":"BSI, full-scope Notified Body for all three types of devices pursuant to MDR and IVDR, is able to offer verification services for compliance with European directives about the production of medical devices","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/10\/AdobeStock_716611374-scaled.jpeg","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2024\/10\/AdobeStock_716611374-scaled.jpeg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/digital-health\/medical-devices\/ce-marking-for-substance-based-medical-devices-and-drug-device-combination-products\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"CE marking for substance-based medical devices and drug-device combination products"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/74848807effaacf75c805dd345082918","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/20612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=20612"}],"version-history":[{"count":4,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/20612\/revisions"}],"predecessor-version":[{"id":20827,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/20612\/revisions\/20827"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/20823"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=20612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=20612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=20612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}